Charles Baker‐Glenn

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 160 citations · Full text

Small Molecule Inhibitors, Broad Kinase Selectivity, Drug Target +19

Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Bryan Chan, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2013 · 121 citations · Full text

Total Synthesis of (−)‐Ulapualide A: The Danger of Overdependence on NMR Spectroscopy in Assignment of Stereochemistry

Gerald Pattenden, Neil J. Ashweek, Charles Baker‐Glenn et al. · Angewandte Chemie International Edition · 2007 · 51 citations

Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor

Bryan Chan, Anthony A. Estrada, Huifen Chen et al. · ACS Medicinal Chemistry Letters · 2012 · 44 citations · Full text

Medicinal Chemistry, Aniline Bioisosteres, Biochemistry +12

A Catalytic Asymmetric Bioorganic Route to Enantioenriched Tetrahydro- and Dihydropyranones

Charles Baker‐Glenn, Neil S. Hodnett, Maud Reiter et al. · Journal of the American Chemical Society · 2005 · 41 citations

Combinatorial Chemistry, Bioorganic Chemistry, Engineering +16